Teva Pharmaceutical Industries (TEVA) Cash & Equivalents (2009 - 2026)
Teva Pharmaceutical Industries' Cash & Equivalents was $3.66 billion in Q2 2026, up 69.1% from $2.16 billion a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Teva Pharmaceutical Industries came in at $3.56 billion, up 7.8% from FY2024.
- Cash & Equivalents has now increased for four consecutive years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $3.3 billion in FY2024 (+2.3%), $3.23 billion in FY2023 (+15.2%), $2.8 billion in FY2022 (+29.4%) and $2.17 billion in FY2021 (-0.6%).
- Quarterly Cash & Equivalents has moved between $1.7 billion (Q1 2025) and $3.74 billion (Q1 2026) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for three straight quarters, with growth averaging 20.8% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 120.4%); the worst was Q1 2025 (a decline of 43.3%).
- Per Business Quant data, TEVA's Cash & Equivalents in the three quarters before Q2 2026 was $3.74 billion (Q1 2026), $3.56 billion (Q4 2025) and $2.2 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 3.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Bn |
| Mar 31, 2026 | 3.74 Bn |
| Dec 31, 2025 | 3.56 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 2.16 Bn |
| Mar 31, 2025 | 1.70 Bn |
| Dec 31, 2024 | 3.30 Bn |
| Sep 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 2.26 Bn |
| Mar 31, 2024 | 2.99 Bn |
| Dec 31, 2023 | 3.23 Bn |
| Sep 30, 2023 | 2.25 Bn |
| Jun 30, 2023 | 2.67 Bn |
| Mar 31, 2023 | 2.14 Bn |
| Dec 31, 2022 | 2.80 Bn |
| Sep 30, 2022 | 2.23 Bn |
| Jun 30, 2022 | 2.06 Bn |
| Mar 31, 2022 | 2.18 Bn |
| Dec 31, 2021 | 2.17 Bn |
| Sep 30, 2021 | 2.05 Bn |
API Access
Teva Pharmaceutical Industries Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();